News
ReNeuron's latest press releases
ReNeuron to present at BMO Capital Markets US healthcare conference. 28/11/07
Guildford, UK, 28 November 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will be participating in the BMO Capital Markets Focus on …
Read articleReNeuron welcomes ground-breaking research on gene-based reprogramming of human stem cells. 21/11/07
Guildford, UK, 21 November 2007: ReNeuron Group plc (LSE:RENE.L) today welcomes the publication of ground-breaking research into the reprogramming of …
ReNeuron to present positive pre-clinical data concerning its ReN005 stem cell line for Huntington's disease. 18/10/07
Guildford, UK, 18 Oct 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will be participating in the 3rd World Congress on Regenerative …
ReNeuron gives AGM update on its ReN001 stem cell therapy for stroke. 06/09/07
Guildford, UK, 6 September 2007: ReNeuron Group plc (LSE: RENE) today announces an update on progress with its ReN001 stem cell therapy for stroke, …
Results of 2007 Annual General Meeting. 06/09/07
Guildford, UK, 6 September 2007: ReNeuron Group plc (LSE: RENE) announces that all resolutions put to its shareholders at today's 2007 Annual General …
ReNeuron announces compliance with AIM Rule 26. 20/08/07
ReNeuron Group plc (LSE: RENE.L) is pleased to announce that the information required by Rule 26 of the AIM Rules for Companies (Company Information …
Notification of increase in issued share capital. 07/08/07
Guildford, UK: ReNeuron Group plc (LSE: RENE.L) announces that on 1 August 2007 it allotted and issued 16,476,190 new ordinary shares of 1 pence each …
ReNeuron acquires business assets of AmCyte Inc. for $4m. 27/07/07
Guildford, UK, 27 July 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it has entered into arrangements pursuant to which ReNeuron will …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page